Market Research Report
Dual Chamber Syringes & Injectors to 2026
|Published by||Greystone Research Associates||Product code||962840|
Delivery time: 1-2 business days
|Dual Chamber Syringes & Injectors to 2026|
|Published: October 5, 2020||Content info:||
Dual chamber injection devices can be classified as either dual chamber syringes or dual chamber pen injectors. The Pen injector segment can be further divided into single-use dual chamber pen injectors and reusable dual chamber pen injectors. The latter relies on the use of a replaceable dual chamber cartridge that is inserted into the pen injector prior to use. While the use of dual chamber devices represents a cost premium for drug marketers relative to competing reconstitution methods such as vial adaptors, it also provides an opportunity for branding.
Dual chamber injection device demand is being driven by the growing number of lyophilized drugs and the need to reconstitute them before they can be administered. Currently only a small number of lyophilized drugs are packaged, or bundled, with reconstitution devices - most lyophilized drugs for injection are typically sold in vials packaged with a diluent syringe - but this is changing as improved dual chamber device designs enter the market.